血液製剤市場- 世界の産業規模、シェア、動向、機会、予測、製品別、タイプ別、用途別、地域別セグメント、競合、2020年～2030年

血液製剤の世界市場規模は2024年に435億7,000万米ドルで、予測期間中のCAGRは6.22%で2030年には625億7,000万米ドルに達すると予測されています。

世界の血液製剤市場は、ヘルスケアおよび製薬業界のダイナミックかつ重要な構成要素であり、様々な医療用途における血液および血液関連製品の可用性と安全性を確保することを目的とした幅広い製品とサービスを包含しています。この市場は、救命輸血、治療、研究に不可欠な血液成分、血漿、その他の血液派生物の処理、検査、流通を中心に展開されています。患者の安全性が重視されるようになり、高度で高品質な血液製剤製品とサービスに対する需要は着実に増加しています。

市場促進要因

慢性疾患の流行

主な市場課題

厳しい規制遵守

主要市場動向

血液製剤における技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の血液製剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（全血、血液成分、血液誘導体）
  • タイプ別（血小板凝集抑制剤、線維素溶解剤、抗凝固剤）
  • 用途別（血小板増多症、肺塞栓症、腎機能障害、狭心症血管合併症、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • 製品別
  • タイプ別
  • 用途別
  • 地域別

第5章 アジア太平洋地域の血液製剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別
  • タイプ別
  • 用途別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の血液製剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の血液製剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の血液製剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの血液製剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の血液製剤市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Pfizer, Inc.
• Bristol-Myers Squibb Company
• Leo Pharma A/S
• Sanofi
• Xiamen Hisunny Chemical Co., LTD
• AstraZeneca plc
• Baxter International Inc
• Portola Pharmaceuticals, Inc.
• GlaxoSmithKline PLC
• Shandong East Chemical Industry Co.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Blood Preparation Market was valued at USD 43.57 billion in 2024 and is expected to reach USD 62.57 billion by 2030 with a CAGR of 6.22% during the forecast period. The Global Blood Preparation Market is a dynamic and critical component of the healthcare and pharmaceutical industry, encompassing a wide range of products and services aimed at ensuring the availability and safety of blood and blood-related products for various medical applications. This market revolves around the processing, testing, and distribution of blood components, plasma, and other blood derivatives, vital for life-saving transfusions, therapeutic treatments, and research. With a growing emphasis on patient safety, the demand for advanced and high-quality blood preparation products and services has been steadily increasing.

Key Market Drivers

Prevalence of Chronic Diseases

The prevalence of chronic diseases is a primary driver behind the rapid growth of the Global Blood Preparation Market. Chronic diseases, which encompass a wide range of conditions such as cancer, anemia, hemophilia, and blood disorders, often necessitate frequent blood transfusions as an integral part of their management and treatment. This demand for blood and blood-related products is escalating due to the increasing global burden of chronic diseases.

As populations age and lifestyles become increasingly sedentary, the incidence of chronic diseases continues to rise. Conditions like diabetes, cardiovascular diseases, and cancer have become more common, leading to a growing need for blood preparations. For instance, cancer patients often require regular blood transfusions to manage the anemia and low platelet counts associated with chemotherapy, while individuals with blood disorders like sickle cell anemia depend on blood transfusions to alleviate their symptoms and complications.

Key Market Challenges

Stringent Regulatory Compliance

The Global Blood Preparation Market, a crucial pillar of healthcare, faces a formidable challenge in the form of stringent regulatory compliance. While regulations are essential to ensuring the safety and efficacy of blood and blood-related products, the stringent nature of these requirements can impede the market's growth and operational efficiency.

Blood preparation involves a complex set of processes, from collection and testing to storage and distribution. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), set stringent standards that must be met to guarantee the safety and quality of blood products. These standards encompass numerous facets of the blood preparation process, including donor eligibility criteria, testing protocols, documentation, and the maintenance of storage and transportation conditions.

Meeting these rigorous regulatory requirements can be a resource-intensive endeavor, particularly for smaller blood banks and healthcare providers. Compliance demands substantial investments in state-of-the-art equipment, quality control measures, staff training, and infrastructure. These expenses can be cost-prohibitive for smaller organizations, potentially limiting their ability to participate in the market. Furthermore, the constant need to adapt to evolving regulations places an ongoing financial burden on stakeholders within the blood preparation industry.

Key Market Trends

Technological Advancements in Blood Preparation

Technological advancements in blood preparation are playing a pivotal role in boosting the Global Blood Preparation Market. Automation, sophisticated equipment, and innovative methods have ushered in a new era of efficiency, safety, and quality within the industry. These advancements are reshaping the landscape of blood collection, processing, and storage, leading to an enhanced market with numerous benefits for healthcare providers and patients alike.

Automation, in particular, stands out as a game-changer in the field. Automated blood preparation systems have revolutionized the industry by significantly reducing human error, enhancing precision, and accelerating the speed at which blood components can be prepared. Automated equipment can process large volumes of blood with unmatched precision, resulting in a more consistent and reliable supply of blood products. This not only improves operational efficiency but also reduces the margin of error, ensuring that the final products meet the highest quality and safety standards.

Moreover, innovative methods and technologies have paved the way for more advanced testing and screening processes. The introduction of nucleic acid testing (NAT), for instance, has significantly enhanced the sensitivity and accuracy of detecting infectious agents, such as HIV, hepatitis B and C. This improvement in blood safety has instilled greater confidence among healthcare professionals and the public, reassuring them that blood products are less likely to transmit infections or other complications.

Key Market Players

• Pfizer, Inc.
• Bristol-Myers Squibb Company
• Leo Pharma A/S
• Sanofi
• Xiamen Hisunny Chemical Co., LTD
• AstraZeneca plc
• Baxter International Inc
• Portola Pharmaceuticals, Inc.
• GlaxoSmithKline PLC
• Shandong East Chemical Industry Co.

Report Scope:

In this report, the Global Blood Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Preparation Market, By Product:

• Whole Blood
• Blood Components
• Blood Derivatives

Blood Preparation Market, By Type:

• Platelet Aggregation Inhibitors
• Fibrinolytics
• Anticoagulants

Blood Preparation Market, By Application:

• Thrombocytosis
• Pulmonary Embolism
• Renal Impairment
• Angina Blood Vessel Complications
• Others

Blood Preparation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Preparation Market.

Available Customizations:

Global Blood Preparation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Blood Preparation Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product (Whole Blood, Blood Components, Blood Derivatives)
  • 4.2.2. By Type (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants)
  • 4.2.3. By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Product
  • 4.3.2. By Type
  • 4.3.3. By Application
  • 4.3.4. By Region

5. Asia Pacific Blood Preparation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By Type
  • 5.2.3. By Application
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Blood Preparation Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product
      • 5.3.1.2.2. By Type
      • 5.3.1.2.3. By Application
  • 5.3.2. India Blood Preparation Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product
      • 5.3.2.2.2. By Type
      • 5.3.2.2.3. By Application
  • 5.3.3. Australia Blood Preparation Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product
      • 5.3.3.2.2. By Type
      • 5.3.3.2.3. By Application
  • 5.3.4. Japan Blood Preparation Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product
      • 5.3.4.2.2. By Type
      • 5.3.4.2.3. By Application
  • 5.3.5. South Korea Blood Preparation Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product
      • 5.3.5.2.2. By Type
      • 5.3.5.2.3. By Application

6. Europe Blood Preparation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Blood Preparation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
  • 6.3.2. Germany Blood Preparation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
  • 6.3.3. Spain Blood Preparation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
  • 6.3.4. Italy Blood Preparation Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By Type
      • 6.3.4.2.3. By Application
  • 6.3.5. United Kingdom Blood Preparation Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By Type
      • 6.3.5.2.3. By Application

7. North America Blood Preparation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Blood Preparation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
  • 7.3.2. Mexico Blood Preparation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
  • 7.3.3. Canada Blood Preparation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application

8. South America Blood Preparation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Blood Preparation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
  • 8.3.2. Argentina Blood Preparation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
  • 8.3.3. Colombia Blood Preparation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application

9. Middle East and Africa Blood Preparation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Blood Preparation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
  • 9.3.2. Saudi Arabia Blood Preparation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
  • 9.3.3. UAE Blood Preparation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Blood Preparation Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Pfizer, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Bristol-Myers Squibb Company
• 14.3. Leo Pharma A/S
• 14.4. Sanofi
• 14.5. Xiamen Hisunny Chemical Co., LTD
• 14.6. AstraZeneca plc
• 14.7. Baxter International Inc
• 14.8. Portola Pharmaceuticals, Inc.
• 14.9. GlaxoSmithKline PLC
• 14.10.Shandong East Chemical Industry Co.

15. Strategic Recommendations

16. About Us & Disclaimer